DR HAMID · HAIR SCIENCE
Female Pattern Hair Loss: Causes, Signs & Treatments
A practical guide to recognising female pattern hair loss, understanding risk factors and choosing evidence-informed treatment options.
Introduction
Female Pattern Hair Loss (FPHL) is a common condition that becomes more prevalent with age and may affect women’s confidence and wellbeing. It usually causes gradual thinning over the central scalp rather than complete hair loss. Understanding its pattern, possible contributing factors and available treatments can help women seek appropriate care. [1, 2, 3]
What Is Female Pattern Hair Loss?
FPHL is a non-scarring form of hair loss in which hair follicles gradually produce thinner, shorter and less pigmented strands — a process called follicular miniaturisation. Genetics and hormonal signalling may contribute, although the precise mechanisms differ between individuals. Dihydrotestosterone (DHT) can contribute to androgen-related miniaturisation, but not every woman with FPHL has elevated androgen levels. [2, 3]
Signs and Symptoms
FPHL often begins with widening of the central hair part and reduced density over the crown. In some women, the thinning forms a triangular or “Christmas tree” pattern toward the front of the scalp, while the frontal hairline is relatively preserved. Sudden shedding, scalp pain, inflammation or patchy bald spots may point to another condition and warrant assessment.
How FPHL Relates to General Health
Some women with hair loss also have conditions such as polycystic ovary syndrome (PCOS), thyroid disorders or metabolic risk factors. Research has identified associations between certain patterns of hair loss and cardiometabolic outcomes, but an association does not establish that hair loss causes these conditions. A healthcare professional can decide whether hormone, thyroid or other testing is appropriate based on symptoms and history. [4, 5, 6]
Risk Factors
Age
FPHL generally becomes more common with increasing age.
Family History
Inherited susceptibility can influence who develops patterned thinning.
Lifestyle and Hair Practices
Smoking, stress and damaging styling practices may influence overall hair or scalp health.
Underlying Conditions
Hormonal changes, thyroid disorders and nutritional deficiencies can contribute to thinning or coexist with FPHL.
Hair loss can also carry a substantial emotional burden, affecting self-image, social wellbeing and daily confidence.
Diagnosis of FPHL
Diagnosis typically involves a medical history and scalp examination, sometimes supported by dermoscopy (trichoscopy). Blood tests may be useful when signs suggest iron deficiency, thyroid disease or another contributing problem. Rapid loss, marked shedding, scalp redness or scarring requires further investigation. [7, 8]
Treatment Options
01 · Topical Treatments
Minoxidil: A commonly recommended first-line treatment for FPHL. Topical 2% and 5% formulations are used in different regimens. Many women experience reduced shedding or improved hair density over several months, although results vary and continued use is usually needed to maintain benefit.
02 · Prescription Oral Treatments
Spironolactone: An anti-androgen medication sometimes prescribed for selected women. It requires medical supervision and is unsuitable during pregnancy.
Low-dose oral minoxidil: Sometimes prescribed off-label by clinicians. Monitoring is important because it may cause side effects such as excess body-hair growth, fluid retention or cardiovascular symptoms.
03 · Lifestyle & Gentle Hair Care
- Avoid frequent heat damage, harsh chemical treatments and tight, traction-producing hairstyles.
- Use gentle drying and detangling methods to reduce breakage.
- Address diagnosed nutritional deficiencies and other relevant health issues.
04 · Camouflage Techniques
Keratin fibres, tinted scalp products and styling techniques may make thinning less visible. They improve appearance but do not treat the underlying process.
05 · Supportive Hair-Care Products
Gentle shampoos, conditioners and scalp-care products may support comfort, reduce breakage and improve the appearance of hair. Their effects should not be confused with clinically established regrowth from treatments such as minoxidil. Product-specific claims should be supported by evidence. [9, 10]
Discover the Dr Hamid range for a gentle, consistent hair-care routine alongside professional advice when needed.
View Hair-Care CollectionCounselling Points for Women with FPHL
- Set realistic expectations: FPHL can often be managed, but treatment response differs and a complete cure cannot be guaranteed.
- Be consistent: Many evidence-based treatments take at least 3–6 months before changes become noticeable; maintenance may be necessary.
- Protect existing hair: Use gentle brushes and minimise heat or traction damage.
- Seek support: Discuss distress or significant impact on wellbeing with a healthcare professional.
Conclusion
Female Pattern Hair Loss can affect physical appearance and emotional wellbeing. An accurate diagnosis, appropriate medical treatment when indicated and careful hair-care practices offer a realistic, individualised approach. Early assessment can help distinguish FPHL from other treatable causes of shedding.
Scientific References
- Female pattern hair loss: Current treatment concepts.
- Bertoli MJ, Sadoughifar R, Schwartz RA, Lotti TM, Janniger CK. Female pattern hair loss: A comprehensive review. Dermatol Ther. 2020 Nov;33(6):e14055.
- Vujovic A, Del Marmol V. The Female Pattern Hair Loss: Review of Etiopathogenesis and Diagnosis. BioMed Research International. 2014;2014:1–8.
- Su LH, Chen LS, Lin SC, Chen HH. Association of Androgenetic Alopecia With Mortality From Diabetes Mellitus and Heart Disease. JAMA Dermatol. 2013 May 1;149(5):601.
- Su LH, Chen LS, Chen HH. Factors associated with female pattern hair loss and its prevalence in Taiwanese women: A community-based survey. Journal of the American Academy of Dermatology. 2013 Aug;69(2):e69–77.
- Arias-Santiago S, Gutiérrez-Salmerón MT, Buendía-Eisman A, Girón-Prieto MS, Naranjo-Sintes R. Hypertension and aldosterone levels in women with early-onset androgenetic alopecia: Hypertension and aldosterone levels in women with early-onset AGA. British Journal of Dermatology. 2010 Apr;162(4):786–9.
- Mubki T, Rudnicka L, Olszewska M, Shapiro J. Evaluation and diagnosis of the hair loss patient: part I. History and clinical examination. J Am Acad Dermatol. 2014 Sep;71(3):415.e1-415.e15.
- Ahanogbe I, Gavino ACP. Evaluation and Management of the Hair Loss Patient in the Primary Care Setting. Primary Care: Clinics in Office Practice. 2015 Dec;42(4):569–89.
- Brough KR, Torgerson RR. Hormonal therapy in female pattern hair loss. International Journal of Women’s Dermatology. 2017 Mar;3(1):53–7.
- Emer J, Lauren Levy LL. Female pattern alopecia: current perspectives. IJWH. 2013 Aug;541.
Reference 1 appears without complete bibliographic details in the original article; its citation has been preserved as supplied.






Leave a comment
This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.